|
Cardiology
Long-term cardiovascular events in hypertensive patients: full report of the Korean Hypertension Cohort
Jin Young Lee, Jean Kyung Bak, Mina Kim, Ho-Gyun Shin, Kyun-Ik Park, Seung-Pyo Lee, Hee-Sun Lee, Ju-Yeun Lee, Kwang-il Kim, Si-Hyuck Kang, Jang Hoon Lee, Se Yong Jang, Ju-Hee Lee, Kye Hun Kim, Jae Yeong Cho, Jae-Hyeong Park, Sue K. Park, Hae-Young Lee
Korean J Intern Med. 2023;38(1):56-67. Published online December 14, 2022
Background/Aims: This study evaluated the long-term cardiovascular complications among Korean patients with hypertension and compared them with that of controls without hypertension.
Methods: The Korean Hypertension Cohort (KHC) enrolled 11,043 patients with hypertension and followed them for more ..
|
|
|
The Korean Hypertension Cohort study: design and baseline characteristics
Hae-Young Lee, Ju-Yeon Lee, Ho-Gyun Shin, Song-Hee Cho, Kyun-Ik Park, Gyu-Chul Oh, Seung-Pyo Lee, Hogon Kim, Hee-Sun Lee, Kwang-Il Kim, Si-Hyuck Kang, Jang Hoon Lee, Se Yong Jang, Ju-Hee Lee, Kye Hun Kim, Jae Yeong Cho, Jae-Hyeong Park, Jieun Jang, Sue K. Park, Jean Kyung Bak
Korean J Intern Med. 2021;36(5):1115-1125. Published online July 22, 2021
Background/Aims: Hypertension (HT) has a significant impact on public health and medical expenses. However, HT is a chronic disease that requires the long-term follow-up of a large number of patients.
Methods: The Korean Hypertension Cohort (KHC) study aimed to develop a model for calculating cardi..
|
|
|
Serum levels of carbohydrate antigen 125 in combination with N-terminal pro-brain natriuretic peptide in patients with acute decompensated heart failure
Jae Yong Yoon, Dong Heon Yang, Hyun Jun Cho, Nam Kyun Kim, Chang-Yeon Kim, Jihyun Son, Jae-Hyung Roh, Se Yong Jang, Myung Hwan Bae, Jang Hoon Lee, Hun Sik Park, Yongkeun Cho, Shung Chull Chae
Korean J Intern Med. 2019;34(4):811-818. Published online December 31, 2018
Background/Aims: Carbohydrate antigen 125 (CA-125) is an emerging prognostic biomarker for heart failure. We aimed to test the long-term prognostic value of CA-125 in combination with N-terminal pro-brain natriuretic peptide (NT-proBNP) in patients with acute decompensated heart failure (ADHF).
Met..
|
|
|
Angiotensin II type 1 receptor blockers as a first choice in patients with acute myocardial infarction
Jang Hoon Lee, Myung Hwan Bae, Dong Heon Yang, Hun Sik Park, Yongkeun Cho, Won Kee Lee, Myung Ho Jeong, Young Jo Kim, Myeong Chan Cho, Chong Jin Kim, Shung Chull Chae, Korea Acute Myocardial Infarction Registry Investigators
Korean J Intern Med. 2016;31(2):267-276. Published online December 23, 2015
Background/Aims: Angiotensin II type 1 receptor blockers (ARBs) have not been adequately evaluated in patients without left ventricular (LV) dysfunction or heart failure after acute myocardial infarction (AMI).
Methods: Between November 2005 and January 2008, 6,781 patients who were not receiving a..
|
|
|
